Fiera Capital Corp

Position in GILD — Gilead Sciences, Inc.

CIK 1505817 MONTREAL, A8

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$26,179,795

+$59,070 QoQ

Shares Held

207,217

+10.6% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#290

of 2,266 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 16% Shared 84% None 0%

Healthcare · as of Jun 30, 2026

Fiera Capital Corp holds $640,231,388 across 6 Drug Manufacturers - General names. GILD ranks #4 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,894,762	$481,212,704
2	LLY	ELI LILLY & Co	47,526	$57,004,114
3	MRK	Merck & Co., Inc.	223,353	$28,700,860
4	GILD	Gilead Sciences, Inc. This page	207,217	$26,179,795
5	AZN	Astrazeneca PLC	124,873	$23,678,417
6	NVS	Novartis AG	149,665	$23,455,498

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,179,795	207,217	+10.6%	Shares	Sole	2026-08-07
2026-03-31	$26,120,725	187,420	+2412.3%	Shares	Other	2026-05-12
2022-12-31	$640,441	7,460	-79.4%	Shares	Sole	2023-02-08
2022-09-30	$2,235,337	36,235	+7.4%	Shares	Sole	2022-11-03
2022-06-30	$2,085,160	33,735	+139.9%	Shares	Sole	2022-08-10
2022-03-31	$835,867	14,060	-55.0%	Shares	Sole	2022-05-09
2021-12-31	$2,268,336	31,240	-24.3%	Shares	Sole	2022-02-08
2021-09-30	$2,884,455	41,295	+11.4%	Shares	Sole	2021-11-12
2021-06-30	$2,552,295	37,065	+39.7%	Shares	Sole	2021-08-16
2021-03-31	$1,714,310	26,525	-3.5%	Shares	Sole	2021-05-11
2020-12-31	$1,602,150	27,500	+720.7%	Shares	Sole	2021-02-09
2020-06-30	$257,825	3,351	-91.3%	Shares	Other	2020-08-07
2020-03-31	$2,878,185	38,499	—	Shares	Other	2020-05-08
No filing history on record for this holder in this stock.